Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MESA vs ESA with Radiotherapy in Early Stage ENKTL
NCT02631239Phase 3Unknown
- Sponsor
- Ruijin Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate in Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT), sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Extranodal NK/T-cell lymphoma nasal type (ENKTCL-NT)
Beyond the preview
Go deeper on NCT02631239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02631239.